Because
of the formidable development of the asymmetric reduction
of tetrasubstituted olefins, an effective method is in urgent demand.
Herein, through the biomimetic protocol of the coenzyme NAD(P)H, the
reduction of tetrasubstituted olefin 2,3-substituted 1H-inden-1-ones has been successfully realized with the catalytic chiral
NAD(P)H model CYNAM, which is hard to bring about via the common rhodium
or iridium-based catalytic system, producing the corresponding products
in good yield (up to 98%) with good enantioselectivity (up to 99%
ee). Furthermore, the chiral bioactive molecule can be concisely synthesized
from the reduced product